TSXV - Delayed Quote CAD

Sirona Biochem Corp. (SBM.V)

0.0650 0.0000 (0.00%)
At close: April 22 at 3:59 PM EDT

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.
NameTitlePayExercisedYear Born
Dr. Howard J. Verrico M.D., Ph.D. Founder, Chairman of the Board, CEO & Secretary 180.64k -- 1961
Mr. Christopher D. Hopton C.G.A., CPA CFO & Director 147.84k -- 1966
Dr. Géraldine Deliencourt-Godefroy Ph.D. Chief Scientific Officer & Director 213.39k -- --

Sirona Biochem Corp.

595 Burrard Street
Vancouver, BC V7X 1L4
Canada
604-641-4466 https://www.sironabiochem.com
Sector: 
Healthcare
Industry: 
Biotechnology

Description

Sirona Biochem Corp., a cosmetic ingredient and drug discovery company, develops and sells cosmetic and pharmaceutical active ingredients in Canada and France. Its programs include cosmetic skin lightener and diabetes drug; and other projects comprise the development of an anti-aging/cell protection library, novel anti-wrinkle compound, and anti-viral program. The company was formerly known as High Rider Capital Inc. and changed its name to Sirona Biochem Corp. in May 2009. Sirona Biochem Corp. was incorporated in 2006 and is headquartered in Vancouver, Canada.

Corporate Governance

Sirona Biochem Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

  • Dec 27, 2006
    Ex-Dividend Date

Upcoming Events

Jun 27, 2024 - Jul 01, 2024
Sirona Biochem Corp. Earnings Call

Related Tickers